Aeropac

Aeropac67 mg/ml

Simethicone

Amico Laboratories Ltd.

Product Code : 378
MRP 30.00
10% Off
Best PriceTk
/
Out Of Stock
1
Section

Alternatives

See All
Product Image
10% Off

Lefoam67 mg/ml

Simethicone

Incepta Pharmaceuticals Ltd.

27.00
30.00
Out Of Stock
Product Image
10% Off

Semecon67 mg/ml

Simethicone

Drug International Ltd.

41.40
46.00
Add to cart
Product Image
10% Off

Bloatnil67 mg/ml

Simethicone

Navana Pharmaceuticals Ltd.

31.50
35.00
Add to cart
Product Image
10% Off

Flatulex67 mg/ml

Simethicone

Opsonin Pharma Ltd.

31.60
35.11
Add to cart
Product Image
10% Off

Flatunil67 mg/ml

Simethicone

ACME Laboratories Ltd.

31.50
35.00
Add to cart
Product Image
10% Off

Neodrop67 mg/ml

Simethicone

Beximco Pharmaceuticals Ltd.

27.00
30.00
Add to cart
Product Image
10% Off

Pedicon67 mg/ml

Simethicone

Orion Pharma Ltd.

27.18
30.20
Out Of Stock
Product Image
10% Off

Pedigas67 mg/ml

Simethicone

Globe Pharmaceuticals Ltd.

27.00
30.00
Out Of Stock
Product Image
10% Off

Simet67 mg/ml

Simethicone

ACI Limited

27.18
30.20
Add to cart
Section

Medicine overview

Indications of Aeropac 67 mg/ml

Flatulence, abdominal distention, fullness, gas and windy colic: Aeropac 67 mg/ml is an excellent and effective antiflatulent. It is used for relief of the painful symptoms of excess gas in the digestive tract. Such gas is frequently caused by excessive swallowing of air or by eating foods ... Read moreFlatulence, abdominal distention, fullness, gas and windy colic: Aeropac 67 mg/ml is an excellent and effective antiflatulent. It is used for relief of the painful symptoms of excess gas in the digestive tract. Such gas is frequently caused by excessive swallowing of air or by eating foods that disagree. Aeropac 67 mg/ml drop is especially used in infants, acts in the stomach and intestines. Thus Aeropac 67 mg/ml enables freeing and eliminating the gas more easily by belching or passing flatus. Large bowel preparation: Addition of Aeropac 67 mg/ml to a polyethylene glycol bowel preparation produces symptomatic improvement prior to investigation in the management of accidental ingestion of foaming detergents. Treatment of poisoning: Aeropac 67 mg/ml has an anecdotal use as an antifoaming agent in the management of accidental ingestion of foaming detergents.

Theropeutic Class

Anti-dyspeptic/Carminatives

Pharmacology

Aeropac 67 mg/ml is used as an antiflatulent to relieve symptoms commonly referred to gas including upper GI bloating, pressure, fullness or stuffed feeling. The clinical use of Simeticone is based on its antifoaming properties. Its antifoaming action relieves flatulence by dispersing and preventing the formation of mucous surrounded gas pockets in the GI tract. Simeticone acts in the stomach and intestines to change the surface tension of gas bubbles, enabling them to coalesce; thus gas is freed and eliminated more easily by belching or passing flatus. Simeticone aids in the elimination of gas from the GI tract and can be used to reduce postoperative gas pains. Simeticone can also be used prior to gastroscopy to enhance visualization and prior to radiography of the intestine to reduce gas shadows.

Dosage & Administration of Aeropac 67 mg/ml

Take after meals and at bedtime. Can be given with infant’s feeds. Shake the bottle well before each use. Children less than 2 years of age: 20 mg (0.3 ml Aeropac 67 mg/ml Paediatric Drops) 4 times daily up to 240 mg/day (3.6 ml Aeropac 67 mg/ml Paediatric Drops). Children 2-12 years of age: 40 mg (0.6 ml Aeropac 67 mg/ml Paediatric Drops) 4 times daily. Adults: 40-125 mg or 1-3 Aeropac 67 mg/ml chewable tablets; 4 times daily, up to 500 mg/day (12 Aeropac 67 mg/ml chewable tablets).

Dosage of Aeropac 67 mg/ml

Take after meals and at bedtime. Can be given with infant's feeds. Shake the bottle well before each use.Children less than 2 years of age: 20 mg (0.3 ml Aeropac 67 mg/ml Paediatric Drops) 4 times daily up to 240 mg/day (3.6 ml Aeropac 67 mg/ml Paediatric Drops).Children 2-12 years of age: 40 mg (0.6 ml Aeropac 67 mg/ml Paediatric Drops) 4 times daily.Adults: 40-125 mg (0.6 ml-1.9 ml Aeropac 67 mg/ml Paediatric Drops) 4 times daily, up to 500 mg/day (7.5 ml Aeropac 67 mg/ml Paediatric Drops) or 1-3 Aeropac 67 mg/ml chewable tablets; 4 times daily, up to 500 mg/day (12 Aeropac 67 mg/ml chewable tablets).

Interaction of Aeropac 67 mg/ml

There is no evidence that Aeropac 67 mg/ml modifies the effect of other drugs. The defoaming effect of Aeropac 67 mg/ml is reduced by antacids such as Aluminium Hydroxide and Magnesium Carbonate, which absorb the Silicone.

Side Effects of Aeropac 67 mg/ml

Aeropac 67 mg/ml is physiologically inert and no adverse effect has been noted after oral ingestion.

Pregnancy & Lactation

Pregnant women: No data are available to suggest any harmful effects.Lactating mother: Excretion of Aeropac 67 mg/ml in breast milk has not been established, and would be most unlikely.

Precautions & Warnings

Do not exceed 12 doses per day except under the advice and supervision of a physician.

Storage Conditions

Should be stored in cool and dry place, protected from light. Keep the medicine out of the reach of children.

Drug Classes

Anti-dyspeptic/Carminatives

Mode Of Action

Aeropac 67 mg/ml is used as an antiflatulent to relieve symptoms commonly referred to gas including upper GI bloating, pressure, fullness or stuffed feeling. The clinical use of Simeticone is based on its antifoaming properties. Its antifoaming action relieves flatulence by dispersing and preventing the formation of mucous surrounded gas pockets in the GI tract. Simeticone acts in the stomach and intestines to change the surface tension of gas bubbles, enabling them to coalesce; thus gas is freed and eliminated more easily by belching or passing flatus. Simeticone aids in the elimination of gas from the GI tract and can be used to reduce postoperative gas pains. Simeticone can also be used prior to gastroscopy to enhance visualization and prior to radiography of the intestine to reduce gas shadows.

Pregnancy

Pregnant women: No data are available to suggest any harmful effects.Lactating mother: Excretion of Aeropac 67 mg/ml in breast milk has not been established, and would be most unlikely.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.